M&A Deal Summary |
|
|---|---|
| Date | 2020-02-11 |
| Target | Strand Diagnostics |
| Sector | Information Technology |
| Buyer(s) | P4 Diagnostix Laboratory Network |
| Deal Type | Add-on Acquisition |
SEARCH BY
P4 Diagnostix Laboratory Network is comprised of four laboratory companies, including Theranostix, Inc. (Beltsville, MD and Brick, NJ), Long Island Pathology, Inc. (East Setauket, NY), Platinum Pathology, LLC (Glen Allen, VA) and Metamark Laboratories, Inc. (Augusta, GA). P4 represents a progressive pathway in healthcare focused on predictive, preventative, personalized and participatory medical practice, beyond diagnosing and treating disease. P4 has multiple centers of excellence: molecular diagnostics, urology, gastroenterology, dermatology, women's health, podiatry, and general surgical pathology.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Indiana M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-03 |
Metamark Laboratories
Waltham, Massachusetts, United States Metamark Laboratories, Inc. is a provider of urology testing services. |
Buy | - |
